Merck Stock’s Potential for Dividend Growth in Retirement

If you’re exploring the pharmaceutical sector, GLP-1 weight-loss therapies are popular, but consider Merck (NYSE: MRK) as a solid investment. Merck offers a dividend yield of 2.8%, significantly higher than the S&P 500’s 1.1% and the average pharmaceutical stock’s 1.7%. This substantial yield, over 60% more than the average drug stock, positions Merck as a reliable choice for long-term wealth accumulation.

Want More Context? 🔎